… thrombin activatable fibrinolysis inhibitor; tPA, tissue-type plasminogen activator; PAI-1,
plasminogen activator inhibitor-… This is, in part, because we lack well-validated tests of fibrinolysis …

… Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with
increased plasma fibrinolysis. Gastroenterology 2001;121:131-139. 7) Leonardi F, Maria N, Villa E…

… inhibitor- 1 antigen (PAI- 1; nv 1- 25 ng/mL), tissue plasminogen activator antigen (t- PA, nv
<10 ng/mL), and activated inactivated thrombin- activatable fibrinolysis inhibitor … for the lack of …

… as acute kidney injury which has been linked to a specific exaggeration of FXIII deficiency in
… to fibrinolysis due to enhanced activation of thrombin-activatable fibrinolysis inhibitor (TAFI). …

… contribution of thrombin-activatable fibrinolysis inhibitor (TAFI… carboxypeptidase inhibitor
(CPI) (25 μl/ml), a specific inhibitor … The role of TAFI deficiency on plasma fibrinolysis in cirrhotic …

… These tests, however, are only sensitive to deficiencies or defects in … with cirrhosis has
been linked to decreased levels of antiplasmin and thrombin-activatable fibrinolysis inhibitor or …

… have demonstrated that patients with liver disease are in a … who have an isolated ADAMTS13
deficiency. Specifically, despite a … inhibitor 1 and decreased levels of thrombin activatable …

… The efficacy of fresh frozen plasma (FFP) transfusion in enhancing thrombin generation in
patients with cirrhosis and impaired conventional coagulation tests has not been sufficiently …

… Thrombin-activatable fibrinolytic inhibitor and PAI-1 were not measured in the present study
because data from PMS in daily clinical practice did not include the special coagulation tests …

… As for fibrinolysis, increased tissue‐type and urokinase‐type plasminogen activators, a …
activator inhibitor 1, and decreased levels of thrombin‐activatable fibrinolysis inhibitor and α2‐…